#1INVESTOR PRESENTATION AUGUST 2021 ♡ BEAUTYHEALTH™#2DISCLAIMER This Presentation contains certain forward-looking statements. These statements may be made directly in this Presentation. Some of the forward-looking statements can be identified by the use of forward-looking words. Statements that are not historical in nature, including the words "anticipate," "expect," "suggests," "plan," "believe," "intend," "estimates," "targets," "projects," "should," "could," "would," "may," "will," "forecast" and other similar expressions are intended to identify forward-looking statements. All forward-looking statements are based upon management estimates and forecasts and reflect the views, assumptions, expectations, and opinions of the Company as of the date of this Presentation, and may include, without limitation, changes in general economic conditions as a result of COVID-19, all of which are accordingly subject to change. Any such estimates, assumptions, expectations, forecasts, views or opinions set forth in this Presentation constitute the Company's judgments and should be regarded as indicative, preliminary and for illustrative purposes only. The forward-looking statements and projections contained in this Presentation are subject to a number of factors, risks and uncertainties, some of which are not currently known to us, that may cause the Company's actual results, performance or financial condition to be materially different from the expectations of future results, performance of financial condition. Although such forward-looking statements have been made in good faith and are based on assumptions we believe to be reasonable, there is no assurance that the expected results will be achieved. Many factors could adversely affect our business and financial performance. We discussed a number of material risks in our definitive proxy filed with the Securities and Exchange Commission on April 7, 2021 and other filings with the Securities and Exchange Commission. Those risks continue to be relevant to our performance and financial condition. Moreover, we operate in a very competitive and rapidly changing environment. New risk factors emerge from time to time and it is not possible for management to predict all such risk factors, nor can it assess the impact of all such risk factors on the business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. We expressly disclaim any responsibility to update forward-looking statements, whether as a result of new information, future events or otherwise. This Presentation also includes outlook for fiscal 2021 that was announced on August 10, 2021. Our fiscal 2021 outlook has not been updated and does not take into consideration any developments since such date. Our achievement of the results included in or prior outlook is subject to risks and uncertainties, including those disclosed in our filings with the Securities and Exchange Commission. Our outlook does not take into account the impact of any unanticipated developments in our business or changes in our operating environment, nor does it take into account any unannounced acquisitions, dispositions or unannounced financings during 2021. In addition, given the uncertainty in the environment we are operating in, we remain cautious of the potential risk for further market closures from new COVID-19 strains and the uneven global rollout of the vaccines. Our outlook assumes a largely reopened global market, which would be negatively impacted if closures persist or are re-implemented. This presentation includes references to non-GAAP financial measures, including but not limited to Adjusted EBITDA. Such non-GAAP measures should be considered only as supplemental to, and not as superior to, financial measures prepared in accordance with GAAP. This Presentation does not constitute an offer or invitation for the sale or purchase of the securities, assets or business described herein or a commitment of the Company with respect to any of the foregoing, and this Presentation shall not form the basis of any contract. This Presentation contains information derived from third party sources, including research, surveys or studies conducted by third parties, information provided by customers and/or industry or general publications. While we believe that such third party information is reliable, we have not independently verified, and make no representation as to the accuracy of, such third party information. This Presentation contains financial forecasts. These projections are for illustrative purposes only and should not be relied upon as being necessarily indicative of future results. Inclusion of the prospective financial information in this presentation should not be regarded as a representation by any person that the results contained in the prospective financial information will be achieved.#3BEAUTYHEALTH MANAGEMENT PRESENTERS CLINT CARNELL Chief Executive Officer Experience: 25 Years LIYUAN WOO Chief Financial Officer Experience: 23 Years ● Ⓡ ● ● ● ● ● CEO of HydraFacial since December 2016 Founder of Orange Twist Head of Surgical for Bausch + Lomb Chief Operating Officer at Solta Medical Johnson & Johnson/Chiron Joined HydraFacial in September 2020 Prior to joining HydraFacial, was the COO and CFO of The VOID, a virtual reality entertainment company Served as CFO for a number of companies such as SharkNinja, Gymboree, and bebe Deloitte M&A and Financial Advisory Services SOLTAMEDICAL BAUSCH + LOMB B Deloitte. ORANGETWIST Your Treatment Shop "GAMBRO. Shark NINJA bebe GYMBOREE 3#4♡ BEAUTYHEALTH™ Deeply Connecting You to the Beauty Health Community Where You Live, Work & Play CONSUMER WE ARE We take the consumer's view, providing them with experiences tailored to their needs EDUCATOR We provide education and support to our core customers, estheticians & providers, to ensure the quality of experiences. for the community 'AND' COMPANY We are an 'and' company, forging strategic partnerships throughout our community. The community we're building benefits everyone - the consumer, customer and our company#5250 200 150 100 50 0 MASSIVE GLOBAL OPPORTUNITY 60 US 2023 Beauty Health Estimated TAM ($Billions) Source: Euromonitor research 2020. Note: TAM estimated calculations consist of Skincare, Personal Care and Haircare markets. 120 Asia 48 EU 12 240 1 Total ROW#6BEAUTY HEALTH CATEGORY CREATOR RESULTS SIMILAR TO A PROFESSIONAL MEDICAL TREATMENT WITH THE EXPERIENCE OF A CONSUMER BRAND SKIN CORRECTION Medical delivery technology-focused Lasers, Ultrasound, Fillers, Toxins SKIN CARE Daily, over-the-counter skin care Serums, Creams, Lotions, Supplements SKIN HEALTH hydrafacial Highly effective, non-invasive and approachable treatment Bridging professional and retail skin care markets#71 CLEANSE hydrafa 2 EXTRACT 3 HYDRATE 3 STEPS. 30 MINUTES. THE BEST SKIN OF YOUR LIFE! Uncover a new layer of skin with gentle exfoliation and relaxing resurfacing, using signature solutions. BASE TIP UPGRADES Remove debris from pores with painless suction. Nourish with intense moisturizers that quench skin. EXTRACTION TIP Saturate the skin's surface with antioxidants and peptides to maximize your glow. VORTEX FUSION TIP $200 Average cost Personalized Treatment Enhancements BOOSTERS Boosters address specific skin concerns such as acne, hyperpigmentation, dry skin and wrinkles Monthly Recommended frequency 15 Boosters of which hydrafacial KERAVIVE Keravive is a relaxing treatment designed to cleanse, exfoliate, nourish, and hydrate the scalp for healthier and fuller-looking hair 8 are partner boosters 7#8GLOBAL SKINCARE & HAIRCARE SALES ($B) 2% CAGR PARTICIPATING IN $201 $206 $212 $218 $217 $77 $77 $77 $78 $78 HIGH-GROWTH $124 $129 $135 $140 $140 CATEGORIES WITHIN PERSONAL CARE SPA SERVICES GROWING ACROSS ALL TYPES OF TREATMENTS, PARTICULARLY IN FACIALS Source: Euromonitor 2020 and 2019. Note: Statistics for Global skincare & haircare reflect post- COVID conditions while all other data is from pre-COVID reports. 2016 $0.8 2017 2016 $0.9 2018 U.S. MED SPA FACIAL TREATMENT SALES ($B) 2017 13% CAGR $1.0 2018 2019 11.1% expected growth in U.S. medical spa services (2017-2025) $1.2 2020 ■Skincare $1.3 $1.5 2019E 2020E 2021E $227 $78 $149 Hair Care 2021E $1.6 4% CAGR 6.4% expected growth in U.S. spa facilities (2017-2022) $243 $80 $155 $162 $235 $79 2022E 2023E 11% CAGR $1.8 2022E 2023E $2.1 2024E $251 $82 $169 2024E $2.3 2025E 14.0% expected growth in U.S. skin care specialists (2016-2026) 8#9$ Do CONSUMERS INCLINED TO SPEND ON BEAUTY & HEALTH EXPERIENTIAL GROWTH IN DISPOSABLE INCOME CHANNEL GROWTH & DYNAMICS INFLUENCERS & SOCIAL MEDIA DRIVING PURCHASE DECISIONS EMBRACING NATURAL & INCLUSIVITY NEXT GEN BEAUTY ● ● ● ● ● ● Aging millennials are spending more on skincare, preferring experiences over products Holistic, in-side-out beauty Increased emphasis on rituals As U.S. economy grows, consumers have more disposable income to spend on premium products Multi-brand retailers (e.g., Sephora) Shift to digital Travel retail Consumers embracing affordable luxury Online demos, which originally gained popularity in cosmetics, are becoming increasingly influential in skincare Skincare increasingly valued in age of selfies/social media Showcasing skin vs covering it up Clean, sustainable, "natural-ish" All-in beauty: gender, age, skin type Personalization Digital beauty#10SKIN HEALTH HYDRAFACIAL IS AN AND COMPANY NOT AN OR COMPANY EXPANDING DEMOGRAPHICS SIGNIFICANT OPPORTUNITY ACROSS CHANNELS FAVORABLE MARKET SHIFTS BENEFITING THE HYDRAFACIAL BUSINESS MODEL Today's consumers are seeking approachable and effective skin health solutions that bridge the gap between OTC and invasive options Facial consumers are more diverse across genders and are younger than ever before, offering a significant market opportunity Consumers seek an experience across all channels of service Source: Third Party Research 2019;reflecting pre-COVID conditions. NON- INVASIVE 27% 95% of HydraFacial customers use other treatments in a year 32% 68% ACROSS GENERATIONS Over 30% of customers at beauty retailers (Ulta, Sephora, etc.) are under 24 43% 27% Spa Service Market Regular and $$ 41% Medical Light Basic Micro Micro- Chemical Lasers Injectables Non- grade therapy facial derma- needling peels skincare brasion 30% ACROSS GENDERS Providers predict ~2x growth in male mix of total facial patients 32% Aesthetics Market 24% Occasional and $$$ 13% Plastic surgical surgery face lifts EXPANDING THE CATEGORY TO ATTRACT NEW DEMOGRAPHICS, WHILE STILL BEING THE TREATMENT OF CHOICE FOR 45+ FEMALES C.L-0 INVASIVE ACROSS GEOGRAPHIES Huge international growth opportunity in Asia & Europe, making up 50% & 20% of the opportunity, respectively Beauty Retail Market Often and $ 10#1151% 2019 Consumables(1) 49% 2019 Delivery Systems 49% 2019 YOY Sales growth THE POWER OF THE NATION PROVIDERS You have to get it, to get it! 48% 2019 YOY Adjusted EBITDA growth THE HYDRAFACIAL NATION Face Life, Face First F $230M - $240M Sales 2021E PARTNERS Wherever, Whenever & Forever... CONSUMERS 3 Steps. 30 Minutes. The Best Skin Of Your Life. $25M Adjusted EBITDA 2021E 40 NPS Score among consumer (Higher than Botox) 80 NPS Score among estheticians 99% "Worth It" rating on RealSelf Source: Third party research 2019; reflects pre-COVID conditions. Note: 2021E figures based on Net Sales guidance provided May 13, 2021, subject to all the qualifications and assumptions as of such date and does not reflect any developments, updates or changes since that date. Adjusted EBITDA is a non-GAAP financial measure. For a description of Adjusted EBITDA and a reconciliation to net loss, please see the Appendix. (1) Excludes Shipping / Other Revenue. Based on 2019A as % to sales. 2019 is more meaningful than 2020 given the pandemic disruption. 11#12THE MASTER PLAN Sell a lot product and use that money to ... Invest in our skincare providers and use that relationship to ● Find the consumers and build a direct relationship. Leverage technology to connect them where they live, work & play. Build the ultimate flywheel of influence! 12#13HYDRAFACIAL NPS RANKS HIGHEST ACROSS BRANDED AESTHETICS AND MEDTECH PEERS NPS N 40 40 38 1,007 38 25 220 25 22 174 22 20 HydraFacial Botox CoolSculpt Lancôme Juvederm Clear + Brilliant 343 20 19 169 19 150 17 17 385 17 Source: Third party research July 2019; reflects pre-COVID conditions. Note: NPS = Net Promoter Score as of 2019; Other brands listed are top 5 treatment and top 5 skincare brands used by HydraFacial users; N = Number of responses. 17 14 151 14 Estée Diamond Clinique Philosophy Origins Lauder Glow 7 457 7 2 190 207 13#14! ● Systems account for 49% of Sales¹ The patented HydraFacial systems generate 3.2M treatments performed annually ● ● TODAY One-time placement generates treatments (revenue) for 3-7 yrs Consumables account for 51% of Sales Every treatment uses Through which flow And customizable ¹Based on 2019A. Excludes Shipping / Other Revenue and Healthy Scalp. BETA-HOBETA-HO ANTIOX-6 CLEAR ludnal CLEAR dal HYDRAFACIAL CTGF DERMABUILDERN Ivindaral J facial 23 ACTIVER TOMORROW Next Gen System connects consumer via app and home handheld device to professional system and the community lebad Idedical HELLO have to d Create Account FIRST SELFIE? 360° CONNECTIVITY KERAVIVE SYSTEM HOME EXTENSION PERK AT RETAIL 14#15LEADING PRESENCE AROUND THE GLOBE Loved in 87 Countries Worldwide 18,000+ Delivery Systems 14 Direct Markets 2021E LOVED AROUND THE WORLD Direct Distributor 15#16POWERFUL FLYWHEEL DESIGNED TO DRIVE COMPETITIVE POSITIONING E GROWING DELIVERY SYSTEMS D FAVORABLE SPA/CLINIC ECONOMICS A DIFFERENTIATED OFFERING ♡ BEAUTYHEALTH™ C PASSIONATE ESTHETICIANS B ENGAGED CONSUMERS Source: Third party research 2019, reflecting Pre-COVID conditions. NPS as of 2019. A Differentiated offering to build brand B Strong base of engaged consumers to fuel growth ● ● Technologically advanced offering with high consumer and provider engagement Customization/Personalization to skin concern ● 50-60% Millennials (vs. ~40% of facial users), a highly engaged demo Passionate esthetician community to recommend HydraFacial Avid social discussion; 5x more Esthetician posts than competitors Estheticians actively recommending (80 NPS; 45% of users learned about HydraFacial from their provider) Estheticians make ~20% more than from a traditional facial . 15% of users get 4+ HydraFacial treatments in a given year 40 NPS (vs. 5-15 NPS for other skincare brands used by our customers) D Favorable spa/clinic economics to increase HydraFacial share Payback of delivery system in ~5 months E Growing installed base to fund new investments As HydraFacial grows, investing in training to expand upon esthetician loyalty Investing in targeted S&M investments to create deeply loved brand and R&D efforts to improve offering/create innovative products 16#17LED BY A VISIONARY AND EXPERIENCED EXECUTIVE TEAM 200+ COLLECTIVE YEARS OF EXPERIENCE within the sector £2002 BEN BAUM Chief Experience Officer CLINT CARNELL Chief Executive Officer Experience: 25 Years SOLTAMEDICAL BAUSCH + LOMB ORANGETWIST Your Treatment Shop S GAMBRO GAMBRO® LIYUAN WOO Chief Financial Officer Experience: 23 Years GYMBOREE bebe Shark NINJA KENDO INDRA PAMAMULL APAC President Experience: 24 Years Deloitte. ONSEN JAPONICA ESTEE LAUDER Experience: 23 Years B TAILORED BRANDS Google OTARGET. TORRID као STEPHAN BAKER EMEA President COTY P&G BCG Experience: 22 Years BOSTON CONSULTING GROUP JWALA KARNIK, M.D. EVP, Global Strategy & Partnerships Experience: 29 Years SUNEVAⓇ MEDICAL Experience: 33 Years DEB RODRIGUEZ Chief Talent Officer Allergan. ioveraº McKinsey & Company Johnson & Johnson BGE Capital VERSANT ventures DAN WATSON EVP, Sales Americas Experience: 36 Years Spectrum ETHICON ENDO-SURGERY, INC. a Johnson Johnson company ORATECH PAUL BOKOTA VP & General Counsel TOSHIBA stryker Experience: 23 Years JamesHardie 17#18NET SALES ($ IN MILLIONS) $48 '16A $16 33% '16A-'19A CAGR: 52% ADJUSTED EBITDA ($ IN MILLIONS) '16A $66 '17A $17 '16A-'19A CAGR: 33% 26% $112 '17A '18A $26 23% '18A GROWTH PROFILE $167 '19A $37 22% '19A $119 ¹20A $8 7% '20A $230 - $240 '21E 13% ¹21E ● ● ● KEY TAKEAWAYS Significant historical revenue growth with 2020 negatively impacted by COVID-19 Rebound experienced in first half 2021 despite continued COVID impact Historically strong adjusted EBITDA performance and an asset light structure that requires minimal CAPEX investment Expecting to invest in growth in 2021 & 2022 through higher expenses and CAPEX $15M 2021 CAPEX spend expected Expect continued strong profitable growth, as well as strong cash flows to support continued investments and M&A activities as we create shareholder value Note: Adjusted EBITDA is a non-GAAP financial measure. For a description of Adjusted EBITDA and a reconciliation to net loss, please see the Appendix. Financial information for periods prior to 2018 is based on internal financial reports. 18#19SÅ RELENTLESSLY INNOVATE AS A CATEGORY CREATOR ● ● Category Ownership - Skin & Scalp Health Launch system 2.0 with personalized services Value added innovation across all touchpoints serums, devices, and experiences Connector platform - Build robust and scalable programs that solidify relationship with aestheticians & providers and end-consumers STRATEGIC INVESTMENTS ● DRIVE CONSUMER DEMAND WITHIN THE COMMUNITY Turn up marketing of the brand, as well as wellness and personalization messaging Accelerate provider engagement through education and events Invest in promotional activities and partnerships EXPAND GLOBAL FOOTPRINT Invest in EMEA and APAC HQs for scaling Convert distributor markets to direct through M&A 8 ACCRETIVE M&A Acquire companies with leading positions in the Beauty Health spectrum o Growth-oriented o High NPS o Recurring revenue characteristics o Attractive margin profile o Leverage our current install base 19#20CONSUMER ENGAGEMENT POWERHOUSE ~3 BILLION Media Impressions Anticipated 2021 Significant ROI on Consumer Activations 170% ~250,000 Provider Searches Anticipated for 2021 16% Instagram Engagement Rate BRIGHTEN HOUNKIE HOUINGIEN life first Source: Third party research 2019, reflecting Pre-COVID conditions. Other data points based on best estimated consumer behavior and previous baseline of purchases drafacial BEAUTYHEALTH PHE 3 allure ENEWS #BLOWvolution Indrafacial VOGUE Forbes InStyle #GLOWvolution ESTIPALOOZA Reader's digest face life face first BRIT+CO 29 REFINERY29 POPSUGAR. BAZAAR US W 20#21hydrafacial CONNECT Goal to be the world's largest educator and deployer of aesthetic professionals. drafa PROVIDER & AESTHETICIAN EDUCATION drafac hydr HFX THE HYDRAFACIAL EXPERIENCE hydr hydraf Gunkiejunkie CONNECT HYDRAFACIAL CERTIFIED PROFESSIONAL Glow On #HydraFaciala HFX: 2-day HydraFacial Experience CONNECT HYDRAFACIAL CERTIFIED EXPERT CONNECT "This is everything I wish I would have learned in aesthetics school." HYDRAFACIAL CERTIFIED MASTER Podcasts Expert Hours Business Building Webinars Treatment Protocol Webinars 21#22i GLOW We are investing in sales & marketing globally to grow consumer demand... AND we are scaling our infrastructure to support pa EXPECT EVERYTHING hydrafac THAT #GLOW THAT #GLOW EXPECT F hyd INTERNATIONAL SCALING VRELAZBAANRA I'M PROUD TO BE A #GUNKIEJUNKIE hydrafacial HEALTHY LOOKING HAIR STARTS WITH A HEALTHIER ALP I GOT THAT #GLOW hydrafacial hydrafacial EXPECT EVERYTH hydrafacial CHILDR O PERUSKAN TENtions 410 hydrafacial Pictured: London, Dubai, & Shanghai - 2021 pop ups & plans for permanent flagship storefronts 1490. SEE WHAT HYDRAFACIAL CAN DO FOR YOU! CALM BRIGHTEN SMOOTH & REFINE EYE hydrafacial RESTORE 6FRM Hydrafacial LEADER HYDRATE SCALP SHOW YOUR SCALP SOME LOVE DISCOVER THE BEST SON OF YOURUFE BENING 22#231 2 3 4 5 6 7 INVESTMENT HIGHLIGHTS CATEGORY CREATING PRODUCT CUSTOMER LOYALTY COMMANDING PLATFORM MULTI-DIMENSIONAL GROWTH OPPORTUNITIES COMPELLING ECONOMIC PROFILE PROPRIETARY TECHNOLOGY EXPERIENCED MANAGEMENT AND BOARD ● ● ● ● Innovative product extension into IOT with data connection, personalization and clean beauty in skin and scalp health High NPS scores in the industry Leading engagement rates on social media Favorable press coverage & attendance at global pop-ups Large install base continues to grow Established partnerships across many channels Digitally and categorically Organically through innovative R&D and through M&A Across skin (face and body) and scalp High margin equipment and consumables Vertically integrated supply chain Patented technology Successfully prosecuted challengers of trademarks, IP, and litigated across the globe Deep aesthetic expertise in the CEO and Board Experienced executive management team 23#24APPENDIX-SUPPLEMENTAL Unaudited (in millions) Net loss Adjusted to exclude the following: Depreciation and amortization expense Interest expense Income tax expense Management fees (1) Facility relocation costs (2) COVID-19 related costs (3) Transaction related costs (4) One-time patent lawsuit cost (5) Other non-recurring and one-time fees (6) Adjusted EBITDA Adjusted EBITDA Margin $ $ MEASURES ADJUSTED EBITDA 2020 (29.2) 14.5 21.3 (9.3) 1.5 3.1 4.2 1.6 7.7 6.5 % $ $ 2019 (1.6) NON-GAAP FINANCIAL 13.9 17.1 (1.3) 1.8 4.0 Fiscal year ended December 31, 1.7 1.4 (0.3) 36.7 22.0 % $ $ 2018 (0.3) 11.5 10.1 0.3 3.2 0.4 1.0 26.2 23.3% $ $ 2017 8.0 10.0 6.6 (11.4) 1.2 3.0 17.4 26.4 % (1) Represents quarterly management fees paid to the majority shareholder of the Company based on a pre-determined formula (including a recapitalization fee of $2.0 million incurred during 2018). Upon consummation of Business Combination, these fees will no longer be paid. Because these fees will not have an ongoing impact, they have been excluded from the calculation of Adjusted EBITDA. (2) Such amounts represent costs associated with the 2019 relocation to a new assembly and warehouse facility that was completed during December 2019. These costs are non- recurring and are directly attributable to the relocation that was finalized in December 2019 and include duplicate rental expense, and the write-off of certain capitalized costs associated with our previous facility. (3) Such costs represent COVID-19 related restructuring costs including write-off of expired consumables, discontinued product lines, human capital and cash management consultant fees in relation to Covid restructuring. (4) Such amounts represent direct costs incurred to prepare the Company to be marketed for sale by the Company's shareholders in previous periods. (5) During 2019, the Company incurred approximately $1.4 million to defend certain patents that were being infringed upon. (6) Such costs primarily represent personnel costs associated with restructuring of HydraFacial's salesforce and costs associated with former warehouse and assembly facility during the transition period offset by a legal settlement received in favor of HydraFacial. $ $ Source: Internal unaudited information for 2016 and 2017. 2018-2020 based on Definitive proxy statement filed on April 7, 2021 with the SEC. Adjusted EBITDA and Adjusted EBITDA Margin are key performance measures that Management uses to assess its operating performance. Because Adjusted EBITDA and Adjusted EBITDA Margin facilitates internal comparisons of the Company's historical operating performance on a more consistent basis, the Company uses these measures for business planning purposes. The Company also believes this information will be useful for investors to facilitate comparisons of its operating performance and better identify trends in its business. The Company calculates Adjusted EBITDA as net income (loss) adjusted to exclude: other (income), net; interest expense; provision for income taxes; depreciation and amortization expense; stock-based compensation expense; and one-time or non-recurring items such as transaction costs, non-recurring legal fees associated with certain actions to defend its intellectual property, manufacturing and freight costs related to inefficiencies due to capacity constraints prior to moving into its new warehouse and assembly facility in December 2019, restructuring costs associated with COVID-19, Management Fees incurred from its private equity owners; and Foreign 2016 (14.0) 3.2 1.0 (2.8) 14.2 13.4 0.7 15.6 32.6 % 24#25♡ BEAUTYHEALTH™ WE ARE A CATEGORY CREATOR... WE ARE DEMONSTRATING EXCITING GROWTH... AND A PROFITABLE & SCALABLE BUSINESS MODEL... IN A MARKET WITH HUGE GLOBAL OPPORTUNITY. 25